Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Rheumatoid Arthritis

  Free Subscription


25.06.2018

3 Arthritis Res Ther
1 Clin Exp Immunol
1 Curr Opin Rheumatol
2 J Rheumatol
2 Lancet
2 PLoS One
2 Rheumatol Int


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arthritis Res Ther

  1. STRAND V, Gossec L, Proudfoot CWJ, Chen CI, et al
    Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis.
    Arthritis Res Ther. 2018;20:129.
    PubMed     Text format     Abstract available

  2. CHEN YL, Jing J, Mo YQ, Ma JD, et al
    Presence of hepatitis B virus in synovium and its clinical significance in rheumatoid arthritis.
    Arthritis Res Ther. 2018;20:130.
    PubMed     Text format     Abstract available

  3. MANDL T, Marsal J, Olsson P, Ohlsson B, et al
    Severe intestinal dysbiosis is prevalent in primary Sjogren's syndrome and is associated with systemic disease activity.
    Arthritis Res Ther. 2017;19:237.
    PubMed     Text format     Abstract available


    Clin Exp Immunol

  4. GANG X, Xu H, Si L, Zhu X, et al
    Treatment effect of CDKN1A on rheumatoid arthritis by mediating proliferation and invasion of fibroblast-like synoviocytes cells.
    Clin Exp Immunol. 2018 Jun 19. doi: 10.1111/cei.13161.
    PubMed     Text format     Abstract available


    Curr Opin Rheumatol

  5. SLOWIKOWSKI K, Wei K, Brenner MB, Raychaudhuri S, et al
    Functional genomics of stromal cells in chronic inflammatory diseases.
    Curr Opin Rheumatol. 2018;30:65-71.
    PubMed     Text format     Abstract available


    J Rheumatol

  6. BERGSTRA SA, Allaart CF, Ramiro S, Chopra A, et al
    Sex-associated Treatment Differences and Their Outcomes in Rheumatoid Arthritis: Results from the METEOR Register.
    J Rheumatol. 2018 Jun 15. pii: jrheum.171176. doi: 10.3899/jrheum.171176.
    PubMed     Text format     Abstract available

  7. BARBER CEH, Thorne JC, Ahluwalia V, Burt J, et al
    Feasibility of Measurement and Adherence to System Performance Measures for Rheumatoid Arthritis in 5 Models of Care.
    J Rheumatol. 2018 Jun 15. pii: jrheum.171284. doi: 10.3899/jrheum.171284.
    PubMed     Text format     Abstract available


    Lancet

  8. GENOVESE MC, Fleischmann R, Combe B, Hall S, et al
    Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial.
    Lancet. 2018 Jun 12. pii: S0140-6736(18)31116.
    PubMed     Text format     Abstract available

  9. BURMESTER GR, Kremer JM, Van den Bosch F, Kivitz A, et al
    Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial.
    Lancet. 2018 Jun 12. pii: S0140-6736(18)31115.
    PubMed     Text format     Abstract available


    PLoS One

  10. PANGA V, Raghunathan S
    A cytokine protein-protein interaction network for identifying key molecules in rheumatoid arthritis.
    PLoS One. 2018;13:e0199530.
    PubMed     Text format     Abstract available

  11. CHOI S, Lee KH
    Correction: Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study.
    PLoS One. 2018;13:e0199468.
    PubMed     Text format     Abstract available


    Rheumatol Int

  12. CASTRO LL, Lanna CCD, Rocha MP, Ribeiro ALP, et al
    Recognition and control of hypertension, diabetes, and dyslipidemia in patients with rheumatoid arthritis.
    Rheumatol Int. 2018 Jun 15. pii: 10.1007/s00296-018-4084.
    PubMed     Text format     Abstract available

  13. VALOR L, Garrido J, Martinez-Estupinan L, Hernandez-Florez D, et al
    Identifying markers of sustained remission in rheumatoid arthritis patients on long-term tapered biological disease-modifying antirheumatic drugs.
    Rheumatol Int. 2018 Jun 18. pii: 10.1007/s00296-018-4087.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: